CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk Healthcare Mangalam Drugs & Organics Ltd

Mangalam Drugs & Organics Ltd

BSE 532637 MANGALAM INE584F01014
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

15 filings · 2 material · busiest 2026-08-12

What it files

Filings

15 in the window

  1. 17 August 2026

    Other Update

    Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure

    Intimation of default under Para A sub- paragraph 6 Schedule III-subsequent default

    Others View filing →

  2. 13 August 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper publication for declaration of Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2026

    Company Update / Newspaper Publication View filing →

  3. 12 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th August, 2026 Interalia For Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June, 2026

    Outcome of Board meeting held on 12th August, 2026 interalia for approval of Un-Audited Financial results (Standalone & Consolidated) for the quarter ended 30th June, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  4. 12 August 2026

    Results

    Declaration Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June, 2026

    Declaration of Un-audited Financial results (Standalone & Consolidated) for the quarter ended 30th June, 2026

    Result / Financial Results View filing →

  5. 12 August 2026

    Auditor Appointment

    Appointment of Statutory Auditor/s

    Appointment of Statutory Auditor for the period of 5 years subject to approval of sharehoders at ensuing 53rd Annual General meeting.

    Company Update / Appointment of Statutory Auditor/s View filing →

  6. 12 August 2026

    General

    Appointment Of Secretarial Auditor Of The Company For Term Of 5 Years Subject To Approval Of Shareholders In Ensuing 53Rd Annaul General Meeting Of The Company

    Appointment of Secretarial Auditor of the Company for term of 5 years from F.Y. 2026-27 to 2030-31 subject to approval of shareholders in ensuing 53rd AGM of the Company

    Company Update / General View filing →

  7. 6 August 2026

    General

    Intimation Of Resignation Tendered By Ragini Chokshi & Co., Secretarial Auditor Of The Company W.E.F. 4Th August, 2026.

    Intimation pursuant to Regulation 30 read with Schedule III of SEBI (LODR), Regulations, 2015 regarding resiagntion tendered by Ragini Chokshi & Co., Secretarial Auditor of the Company ....

    Company Update / General View filing →

  8. 5 August 2026

    Board Meeting

    Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On August 12Th, 2026 Inter Alia To Approve Un-Audited Financial Results(Standalone & Consolidated) Alongwith Limited Review Report For The Quarter Ended 30Th June, 2026.

    Mangalam Drugs & Organics Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Prior Intimation ....

    Board Meeting / Board Meeting View filing →

  9. 16 July 2026

    Other Update

    Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure

    Intimation of subsequent default under Para A sub-paragraph 6 of Schedule III

    Others View filing →

  10. 15 July 2026

    Other Update

    Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure

    Intimation of subsequent default made by Company under Para A sub-Paragraph 6 of Schedule III

    Others View filing →

  11. 13 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Intimation regarding certificate received from Registrar and Transfer agent under Regukation 74(5) of SEBI (DP) Regulations, 2018

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  12. 25 June 2026

    Trading Window

    Closure of Trading Window

    Intimation of closure of trading Window for the period ended 30th June, 2026

    Insider Trading / SAST / Closure of Trading Window View filing →

  13. 18 June 2026

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

    Disclosure of Voting Results and Scrutinizers Report for Postal ballot pursuant to Regulation 44 (3) of SEBI LODR, 2025 for re-appointment of Mr. Praveen Saxena as an Independent Director ....

    AGM/EGM / Postal Ballot View filing →

  14. 18 June 2026

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    Disclosure of Voting Results and Scrutinizers Report for Postal ballot pursuant to Regulation 44 (3) of SEBI LODR, 2025 for re-appointment of Mr. Praveen Saxena as an Independent Director ....

    AGM/EGM / Postal Ballot View filing →

  15. 17 June 2026

    Other Update

    Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure

    Subsequent Disclosure under Regulation 30 part A of Schedule III of SEBI (Listing Obligation and Discloure Requirements) Regulations, 2015 of default of Bank Loan account.

    Others View filing →